257 related articles for article (PubMed ID: 19504612)
1. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.
Braun A; Treede I; Gotthardt D; Tietje A; Zahn A; Ruhwald R; Schoenfeld U; Welsch T; Kienle P; Erben G; Lehmann WD; Fuellekrug J; Stremmel W; Ehehalt R
Inflamm Bowel Dis; 2009 Nov; 15(11):1705-20. PubMed ID: 19504612
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry.
Ehehalt R; Wagenblast J; Erben G; Lehmann WD; Hinz U; Merle U; Stremmel W
Scand J Gastroenterol; 2004 Aug; 39(8):737-42. PubMed ID: 15513358
[TBL] [Abstract][Full Text] [Related]
3. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis.
van der Post S; Jabbar KS; Birchenough G; Arike L; Akhtar N; Sjovall H; Johansson MEV; Hansson GC
Gut; 2019 Dec; 68(12):2142-2151. PubMed ID: 30914450
[TBL] [Abstract][Full Text] [Related]
4. [Mucosal protection by phosphatidylcholine as new therapeutic concept in ulcerative colitis].
Stremmel W
Z Gastroenterol; 2013 Apr; 51(4):384-9. PubMed ID: 23585269
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylcholine (lecithin) and the mucus layer: Evidence of therapeutic efficacy in ulcerative colitis?
Stremmel W; Hanemann A; Ehehalt R; Karner M; Braun A
Dig Dis; 2010; 28(3):490-6. PubMed ID: 20926877
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylcholine as a constituent in the colonic mucosal barrier--physiological and clinical relevance.
Ehehalt R; Braun A; Karner M; Füllekrug J; Stremmel W
Biochim Biophys Acta; 2010 Sep; 1801(9):983-93. PubMed ID: 20595010
[TBL] [Abstract][Full Text] [Related]
7. Aquaporin-8 expression is reduced in ileum and induced in colon of patients with ulcerative colitis.
Zahn A; Moehle C; Langmann T; Ehehalt R; Autschbach F; Stremmel W; Schmitz G
World J Gastroenterol; 2007 Mar; 13(11):1687-95. PubMed ID: 17461471
[TBL] [Abstract][Full Text] [Related]
8. Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation.
Schneider H; Braun A; Füllekrug J; Stremmel W; Ehehalt R
Int J Mol Sci; 2010 Oct; 11(10):4149-64. PubMed ID: 21152327
[TBL] [Abstract][Full Text] [Related]
9. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis.
Pullan RD; Thomas GA; Rhodes M; Newcombe RG; Williams GT; Allen A; Rhodes J
Gut; 1994 Mar; 35(3):353-9. PubMed ID: 8150346
[TBL] [Abstract][Full Text] [Related]
10. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
Strugala V; Dettmar PW; Pearson JP
Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
[TBL] [Abstract][Full Text] [Related]
11. Mucosal protection by phosphatidylcholine.
Stremmel W; Ehehalt R; Staffer S; Stoffels S; Mohr A; Karner M; Braun A
Dig Dis; 2012; 30 Suppl 3():85-91. PubMed ID: 23295697
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis.
Wenzel UA; Magnusson MK; Rydström A; Jonstrand C; Hengst J; Johansson ME; Velcich A; Öhman L; Strid H; Sjövall H; Hansson GC; Wick MJ
PLoS One; 2014; 9(6):e100217. PubMed ID: 24945909
[TBL] [Abstract][Full Text] [Related]
13. Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa.
De Preter V; Bulteel V; Suenaert P; Geboes KP; De Hertogh G; Luypaerts A; Geboes K; Verbeke K; Rutgeerts P
Inflamm Bowel Dis; 2009 Mar; 15(3):335-40. PubMed ID: 18942762
[TBL] [Abstract][Full Text] [Related]
14. Evidence of luminal phosphatidylcholine secretion in rat ileum.
Ehehalt R; Jochims C; Lehmann WD; Erben G; Staffer S; Reininger C; Stremmel W
Biochim Biophys Acta; 2004 Jun; 1682(1-3):63-71. PubMed ID: 15158757
[TBL] [Abstract][Full Text] [Related]
15. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.
Johansson ME; Gustafsson JK; Holmén-Larsson J; Jabbar KS; Xia L; Xu H; Ghishan FK; Carvalho FA; Gewirtz AT; Sjövall H; Hansson GC
Gut; 2014 Feb; 63(2):281-91. PubMed ID: 23426893
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
[TBL] [Abstract][Full Text] [Related]
17. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
19. Colonic mucus, smoking and ulcerative colitis.
Pullan RD
Ann R Coll Surg Engl; 1996 Mar; 78(2):85-91. PubMed ID: 8678464
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of confocal laser endomicroscopy for assessment and monitoring of therapeutic response in patients with inflammatory bowel disease.
Karstensen JG
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]